Published in Acta Oncol on January 01, 1995
Quality assessment in health. Br Med J (Clin Res Ed) (1984) 8.78
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys (1996) 3.42
The Osteopaths Bill. BMJ (1993) 3.16
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer (2005) 2.85
Are cancer cells acidic? Br J Cancer (1991) 2.72
Causes and consequences of tumour acidity and implications for treatment. Mol Med Today (2000) 2.44
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med (2003) 2.44
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. II. Fractionation: recovery and reoxygenation. Br J Radiol (1968) 2.09
District general managers: should they be medically qualified? Br J Hosp Med (1989) 1.93
Biogenesis of mitochondria: the mitochondrial gene (aap1) coding for mitochondrial ATPase subunit 8 in Saccharomyces cerevisiae. Nucleic Acids Res (1983) 1.89
Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia (2000) 1.72
Early and late reactions in skin of rats following irradiation with x-rays or fast neutrons. Radiology (1969) 1.66
Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys (1995) 1.62
Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probes. NMR Biomed (1999) 1.58
5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer (1984) 1.56
Dynamic asymmetry of phosphocreatine concentration and O(2) uptake between the on- and off-transients of moderate- and high-intensity exercise in humans. J Physiol (2002) 1.49
Hyperthermia in the treatment of cancer. Cancer Treat Rev (1979) 1.49
The Ellis formulae for x rays and fast neutrons. Br J Radiol (1972) 1.49
Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed (2001) 1.48
Inferences from pulmonary O2 uptake with respect to intramuscular [phosphocreatine] kinetics during moderate exercise in humans. J Physiol (1999) 1.48
An assessment of 31P MRS as a method of measuring pH in rat tumours. NMR Biomed (1993) 1.45
BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging (2001) 1.44
Repair of radiation damage in Lewis lung carcinoma cells following in situ treatment with fast neutrons and gamma-rays. Cancer Res (1975) 1.42
Hyperparathyroid crisis and posterior mediastinal parathyroid adenoma: a case for preoperative localization. Surgery (1993) 1.38
Effects of fructose on the energy metabolism and acid-base status of the perfused starved-rat liver. A 31phosphorus nuclear magnetic resonance study. Biochem J (1980) 1.32
Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J Magn Reson Imaging (1999) 1.27
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol (2003) 1.27
Simultaneous determination of muscle 31P and O2 uptake kinetics during whole body NMR spectroscopy. J Appl Physiol (1985) (1999) 1.27
Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett (1992) 1.26
Magnetic resonance neurography. Lancet (1993) 1.23
Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer (2003) 1.23
31P-NMR investigation of solid tumours in the living rat. Biosci Rep (1981) 1.20
Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem Int (1990) 1.19
Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS. Magn Reson Med (2003) 1.19
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res (1988) 1.18
The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. Br J Cancer (1997) 1.16
Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. Int J Radiat Oncol Biol Phys (1989) 1.16
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16
Endpoints for damage to normal tissues. Int J Radiat Oncol Biol Phys (1979) 1.15
Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed (1998) 1.14
Renal function after warm ischaemia. II. Marked protective effect of intravenous inosine given prior to 60, 90 and 120 min of warm ischaemia. Eur Urol (1977) 1.14
Effects of fractionated irradiation on mouse lung and a phenomenon of slow repair. Br J Radiol (1976) 1.13
Our healthier nation: alpha for presentation, beta minus for deliverability. J Epidemiol Community Health (1998) 1.10
Insults to the body civil: Mistreatment of elderly in two Plains Indian tribes. J Cross Cult Gerontol (1992) 1.09
Radiobiological aspects of fast neutron therapy. Proc R Soc Med (1972) 1.09
Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumors to carbogen breathing. Magn Reson Imaging (1999) 1.08
Induced thermal resistance in the mouse ear. Br J Radiol (1979) 1.08
An investigation into the clinical effects of fast neutrons. Methods and early observations. Br J Radiol (1971) 1.08
Metabolic consequences of a reversed pH gradient in rat tumors. Cancer Res (1994) 1.07
Do professions have a future? BMJ (1997) 1.07
Linear discriminant analysis of brain tumour (1)H MR spectra: a comparison of classification using whole spectra versus metabolite quantification. NMR Biomed (2007) 1.06
The relationship between heating time and temperature: its relevance to clinical hyperthermia. Radiother Oncol (1983) 1.05
DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study. Magn Reson Med (2011) 1.05
Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans. Br J Cancer (2009) 1.04
Effects of prior exercise on oxygen uptake and phosphocreatine kinetics during high-intensity knee-extension exercise in humans. J Physiol (2001) 1.04
Proton spectroscopy in vivo. Magn Reson Q (1993) 1.04
Effects of dichloroacetate on VO2 and intramuscular 31P metabolite kinetics during high-intensity exercise in humans. J Appl Physiol (1985) (2003) 1.03
The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition. Br J Cancer (2012) 1.03
Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer (1998) 1.02
Application of magnetic resonance neurography in the evaluation of patients with peripheral nerve pathology. J Neurosurg (1996) 1.00
Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy. Br J Cancer Suppl (1996) 1.00
Dynamics of intramuscular 31P-MRS P(i) peak splitting and the slow components of PCr and O2 uptake during exercise. J Appl Physiol (1985) (2002) 0.99
Enhanced preservation of the ischaemic kidney with inosine. Lancet (1976) 0.99
Causes and consequences of acidic pH in tumors: a magnetic resonance study. Adv Enzyme Regul (1999) 0.99
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys (1989) 0.99
Colitis complicating chronic granulomatous disease. A clinicopathological case report. Gut (1996) 0.98
Taurine: a potential marker of apoptosis in gliomas. Br J Cancer (2009) 0.98
Metabolic adaptation in phosphorylase kinase deficiency. Changes in metabolite concentrations during tetanic stimulation of mouse leg muscles. Biochem J (1980) 0.98
In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi-institutional trial. NMR Biomed (2006) 0.98
Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. Br J Cancer (1990) 0.97
Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed (1999) 0.97
The relationship between heating time and temperature for rat tail necrosis with and without occlusion of the blood supply. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 0.97
Magnetic resonance neurography. Magn Reson Med (1992) 0.96
The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism. NMR Biomed (1993) 0.96
Monitoring cancer therapy by NMR spectroscopy. Ann N Y Acad Sci (1987) 0.96
The energy metabolism of RIF-1 tumours following hydralazine. Radiother Oncol (1990) 0.96
The effect of oxygen on impairment of the proliferative capacity of human cells in culture by ionizing radiations of different LET. Int J Radiat Biol Relat Stud Phys Chem Med (1966) 0.96
Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis (2001) 0.95
Glycogenolysis in liver of phosphorylase kinase-deficient rats during liver perfusion and ischaemia. Biochem J (1983) 0.94
The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer (1995) 0.94
Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer (1999) 0.94
Effects of different levels of hypercapnic hyperoxia on tumour R(2)* and arterial blood gases. Magn Reson Imaging (2001) 0.94
Damage to mouse lung with neutrons and x-rays. Eur J Cancer (1974) 0.94
Effects of neutron and X irradiation on cell proliferation in mouse lung. Radiat Res (1981) 0.93
Identification of a 66 KDa protein associated with yeast mitochondrial ATP synthase as heat shock protein hsp60. FEBS Lett (1990) 0.93